Indications and Purposes

1 Indications And Usage Venlafaxine Hydrochloride Extended-Release Capsules, Usp Are Serotonin And Norepinephrine Reuptake Inhibitor (snri) Indicated For The Treatment Of: Major Depressive Disorder (mdd) Social Anxiety Disorder (sad) Panic Disorder (pd) 1.1 Major Depressive Disorder Venlafaxine Hydrochloride Extended-Release Capsules, Usp Are Indicated For The Treatment Of Major Depressive Disorder (mdd). Efficacy Was Established In Three Short-Term (4, 8, And 12 Weeks) And Two Long-Term, Maintenance Trials. 1.3 Social Anxiety Disorder Venlafaxine Hydrochloride Extended-Release Capsules, Usp Are Indicated For The Treatment Of Social Anxiety Disorder (sad), Also Known As Social Phobia. Efficacy Was Established In Four 12-Week And One 26-Week, Placebo-Controlled Trials. 1.4 Panic Disorder Venlafaxine Hydrochloride Extended-Release Capsules, Usp Are Indicated For The Treatment Of Panic Disorder (pd), With Or Without Agoraphobia. Efficacy Was Established In Two 12-Week Placebo-Controlled Trials.

All Formulated Excipients (4 Total)

Name Structure Kind Function Status
1. Sodium Lauryl Sulfate SODIUM LAURYL SULFATE Molecular AF-Antifoaming (or defoaming) agent , CTG-Component or coating , EMUL-Emulsifier , SANI-Sanitizing agent , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.
2. Hypromelloses HYPROMELLOSES Unresolved
3. Gelatin GELATIN Unresolved
4. Ethylcelluloses ETHYLCELLULOSES Unresolved

Active Ingredients ( 0 Total)

None

Comments